Anemia News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Medical mystery: Why was this Labrador retriever suddenly so weak? - Philly.com



Philly.com
 
Medical mystery: Why was this Labrador retriever suddenly so weak? 
Philly.com
Blood work revealed severe anemia, and further analysis specified that she had Heinz bodies and methemoglobinemia, both specific changes of red blood cell destruction. It was possible she had ingested something toxic such as zinc, moth balls, onion, or ...

 


Chemotherapy Induced Anemia Industry Overview with Total Market Share and Distribution of Chemotherapy Induced ... - GEOPOLMonitor



GEOPOLMonitor
 
Chemotherapy Induced Anemia Industry Overview with Total Market Share and Distribution of Chemotherapy Induced ... 
GEOPOLMonitor
?Chemotherapy Induced Anemia ? Market Insights, Epidemiology and Market Forecast ? 2025? report provides an overview of the disease and in depth research related to Chemotherapy Induced Anemia for the 7MM (United States, Germany, France, Italy, Spain ...

and more » 


Sotatercept Effective in Improving Anemia in Patients with MPN-Associated Myelofibrosis - Rare Disease Report



Rare Disease Report
 
Sotatercept Effective in Improving Anemia in Patients with MPN-Associated Myelofibrosis 
Rare Disease Report
MPN-associated myelofibrosis is characterized by a shortage in red blood cells, or anemia, in almost all affected persons. Current treatment options are unsatisfactory, and anemia is notoriously worsened by ruxolitinib, the only U.S. Food and Drug (FDA ...

 


Global Anemia Therapeutics Market 2017- Bayer, GlycoMimetics, GlaxoSmithKline - Silver Pinyon Journal



Silver Pinyon Journal
 
Global Anemia Therapeutics Market 2017- Bayer, GlycoMimetics, GlaxoSmithKline 
Silver Pinyon Journal
Anemia Therapeutics The Global Anemia Therapeutics Market 2017 Report briefly explains it's up to the minute condition in the global market including market capitalization, marketing strategy, current market growth and much more. This report also ...

and more » 


Chemotherapy Induced Anemia Drug Market Therapeutic Survey ... - TechnoPOW (blog)



TechnoPOW (blog)
 
Chemotherapy Induced Anemia Drug Market Therapeutic Survey ... 
TechnoPOW (blog)
Inquire for Chemotherapy Induced Anemia Drug Market Competitive Analysis, Trends and Forecast till 2022, with free sample copy of the report.
Global Anemia Drugs Market (Iron Deficiency, Sickle Cell, CKD ... MilTech
Global Chemotherapy Induced Anemia Drug Market Professional ... satPRnews (press release)
Chemotherapy Induced Anemia Drug Market 2017 ? 3SBio Inc ... The Gulf Feed

all 7 news articles » 


Parvovirus Isn't Risk Factor for Anemia in Patients With HIV - Infectious Disease Special Edition



Parvovirus Isn't Risk Factor for Anemia in Patients With HIV 
Infectious Disease Special Edition
Upon reviewing the results, the researchers found that a significant association neither existed between B19V IgM or DNA and anemia, nor between B19V DNA and HIV load. ?Our results indicate that B19V would not be counted among the important agents that ...

 


Case: Treating Iron Deficiency Anemia in a Heart Failure Patient - Renal and Urology News



Case: Treating Iron Deficiency Anemia in a Heart Failure Patient 
Renal and Urology News
Iron deficiency anemia (IDA) is a common entity in patients with heart failure with reduced ejection fraction (HFrEF), with almost half of patients having either absolute or functional iron deficiency.1 Many HFrEF patients present with iron deficiency ...

 


Bioverativ (BIVV) Announces Investigational BIVV009 Demonstrated Safety, Tolerability and Efficacy in Phase 1b ... - StreetInsider.com



Bioverativ (BIVV) Announces Investigational BIVV009 Demonstrated Safety, Tolerability and Efficacy in Phase 1b ... 
StreetInsider.com
Bioverativ Inc. (NASDAQ: BIVV), a global biopharmaceutical company dedicated to transforming the lives of people with rare blood disorders, today presented data demonstrating that BIVV009, its first-in-class monoclonal antibody currently in Phase 3 ...
Bioverativ's BIVV009 shows positive effect in early-stage study in rare blood disorder; shares ahead 3% Seeking Alpha

all 2 news articles » 


Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer - Dove Medical Press



Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer 
Dove Medical Press
Purpose: Iron deficiency anemia (IDA) is common in cancer patients due to blood loss and inflammation. Many do not tolerate oral iron or adequately respond. Intravenous (IV) iron is commonly used as an adjunct to erythropoiesis-stimulating agents; data ...

 


Darbepoetin Alfa Safe for Pediatric CKD Patients With Anemia - Renal and Urology News



Renal and Urology News
 
Darbepoetin Alfa Safe for Pediatric CKD Patients With Anemia 
Renal and Urology News
Researchers tested once weekly and biweekly administration of darbepoetin alfa in children aged 1 to 18 years not previously treated with an erythropoiesis-stimulating agent. Darbepoetin alfa can be administered safely either weekly or biweekly to ...